Contact Us
Contact Us
Home

[ 00 / 06 ]

[ VISION ]

Nothing is impossible if you believe all things are possible.

Innovate Earlier. Create Smarter. Launch Faster.
Start With TheProblemChange The Way YouThinkTry A NewPathTest NovelSolutionsChange the World

We design, generate, and build solutions with a multi-model construct — one platform, endless possibilities. New paths. New Capabilities. New Solutions. New World.

Our technology is supported by the following partner organizations and companies:

image
image
image
image
image
image
image
image
**** Innovation in biotech stems from the generation and implementation of new ideas that create pathways that have never been traveled. These ideas can range from incremental improvements to existing products, technology, or processes, to radical breakthroughs that disrupt entire industries. **** Innovation in biotech stems from the generation and implementation of new ideas that create pathways that have never been traveled. These ideas can range from incremental improvements to existing products, technology, or processes, to radical breakthroughs that disrupt entire industries. **** Innovation in biotech stems from the generation and implementation of new ideas that create pathways that have never been traveled. These ideas can range from incremental improvements to existing products, technology, or processes, to radical breakthroughs that disrupt entire industries. **** Innovation in biotech stems from the generation and implementation of new ideas that create pathways that have never been traveled. These ideas can range from incremental improvements to existing products, technology, or processes, to radical breakthroughs that disrupt entire industries. **** Innovation in biotech stems from the generation and implementation of new ideas that create pathways that have never been traveled. These ideas can range from incremental improvements to existing products, technology, or processes, to radical breakthroughs that disrupt entire industries. **** Innovation in biotech stems from the generation and implementation of new ideas that create pathways that have never been traveled. These ideas can range from incremental improvements to existing products, technology, or processes, to radical breakthroughs that disrupt entire industries. **** Innovation in biotech stems from the generation and implementation of new ideas that create pathways that have never been traveled. These ideas can range from incremental improvements to existing products, technology, or processes, to radical breakthroughs that disrupt entire industries. **** Innovation in biotech stems from the generation and implementation of new ideas that create pathways that have never been traveled. These ideas can range from incremental improvements to existing products, technology, or processes, to radical breakthroughs that disrupt entire industries.

[ 00 / 06 ]

[ Initiatives ]

The word "IMPOSSIBLE" can be rewritten to say "I'M POSSIBLE". All it takes is a little stroke of the pen in the right location

Our Projects and Successes So Far

From vaccines and therapeutics to genetic sequencing and research , we use the newest technology and fully enabled partners, taking advantage of the latest in-house designed multi-model AI analysis and in-silico tools available. Where a tool does not exist, we create it.

Physalia(TM)

The Physalia(TM) solution relates generally to the fields of molecular biology, synthetic biology, recombinant biotherapeutics, oral drug delivery and endocrinology.

Chirocillus(TM)

The Chirocillus(TM) solution relates generally to the fields of molecular biology, synthetic biology, recombinant biotherapeutics, oral drug delivery and endocrinology.

ReproCeptil(TM)

The ReproCeptil(TM) solution relates generally to the fields of molecular biology, synthetic biology, recombinant biotherapeutics, oral drug delivery and endocrinology.

FeralRX(TM)

The FeralRX(TM) solution relates generally to the fields of molecular biology, synthetic biology, recombinant biotherapeutics, oral drug delivery and endocrinology.

ZPLN(TM)

The ZPLN(TM) solution relates generally to the fields of molecular biology, synthetic biology, recombinant biotherapeutics, oral drug delivery and endocrinology.

Venaticil(TM)

The Venaticil(TM) solution relates generally to the fields of molecular biology, synthetic biology, recombinant biotherapeutics, oral drug delivery and endocrinology.

**** We create our own path. If you travel the path others have followed, you will experience the same sights, sounds, smells and tastes they have experienced. If you take your own path, you have the chance of experiencing something new. Then you create the path for others to follow. **** We create our own path. If you travel the path others have followed, you will experience the same sights, sounds, smells and tastes they have experienced. If you take your own path, you have the chance of experiencing something new. Then you create the path for others to follow. **** We create our own path. If you travel the path others have followed, you will experience the same sights, sounds, smells and tastes they have experienced. If you take your own path, you have the chance of experiencing something new. Then you create the path for others to follow. **** We create our own path. If you travel the path others have followed, you will experience the same sights, sounds, smells and tastes they have experienced. If you take your own path, you have the chance of experiencing something new. Then you create the path for others to follow. **** We create our own path. If you travel the path others have followed, you will experience the same sights, sounds, smells and tastes they have experienced. If you take your own path, you have the chance of experiencing something new. Then you create the path for others to follow.

[ 00 / 06 ]

[ Methodology ]

Our Edge. How We Work Smarter.

A Process Built For Modern Teams. Backed By Cutting-Edge AI.

Sawyer Boone combines powerful AI models with a unified creative workspace — built for speed, clarity, integrity, and control. Our tools simulate laboratory discovery and testing scenarios and actions that can rapidly speed up discovery and design. If we have a need and cannot find a tool, we build it. The time we spend creating a new tool saves 100 fold the time we would be required to spend in the lab or researching solutions. AI is not the solution for us. It is just a tool to help us speed through the volumes of data and the thousands of iterations of testing that leads to success.

Problem Assessment

The evolution of problem identification in biotechnology and immunology has shifted from reactive, trial-and-error experimentation to predictive, data-driven discovery powered by Artificial Intelligence (AI). Historically, identifying a biological bottleneck or a novel disease target took years of manual screening.

Data Collection & Research

We collect as much information and data as we can find about a problem and potential solutions. We focus on the successes but most importantly we focus on the failures that others have experienced. To us a failure is

Solution Acceptance & IP Protection

Once a solution clears our strict criteria for success, the pivot from scientific discovery to commercial asset protection is a critical race against time. In biotech and immunology, a brilliant solution is only as valuable as the intellectual property

Production & Formal Testing

Our lean, asset-light Contract Manufacturing Organization (CMO) and Contract Research Organization (CRO) hybrid model is the cutting-edge standard of modern biotechnology. By decoupling intellectual property generation from heavy brick-and-mortar infrastructure, our organization operates like an elite software firm, scaling

Permitting & Commercialization

Once testing is complete and the data is gathered, analyzed and reported, we submit our results along with our Intellectual Property (IP) packages for nonprovisional patent filing in the US and world patent agencies. At the same time, we

Always Evolving

Success tells you what worked yesterday; failure tells you what to invent tomorrow.  After all seems done and the product is on its way to solve the problem we identified in the beginning of the process, we actually start

**** We start with the problem first. Then we seek answers from the world. If no answers are found or if the answers are incomplete or lacking, then we start to work. **** **** We start with the problem first. Then we seek answers from the world. If no answers are found or if the answers are incomplete or lacking, then we start to work. **** **** We start with the problem first. Then we seek answers from the world. If no answers are found or if the answers are incomplete or lacking, then we start to work. **** **** We start with the problem first. Then we seek answers from the world. If no answers are found or if the answers are incomplete or lacking, then we start to work. **** **** We start with the problem first. Then we seek answers from the world. If no answers are found or if the answers are incomplete or lacking, then we start to work. **** **** We start with the problem first. Then we seek answers from the world. If no answers are found or if the answers are incomplete or lacking, then we start to work. **** **** We start with the problem first. Then we seek answers from the world. If no answers are found or if the answers are incomplete or lacking, then we start to work. ****

[ 00 / 06 ]

[ Motivation ]

How To Get Us To Work On A Problem

From problem to solution in just six steps.

**** If we do not get the results we want, then we go back into the design tools and rework. The beauty of our designs and tools is that they are based on decades of real science and laboratory results and refined through Artifical Intelligence (AI). These are tools we built in-house that help us run through infinitely more iterations of testing in a digital sandbox than we could possibly perform in a wet lab. This provides results that would take a normal pharma or biotech laboratory months or even years to perform. We can retool and retest in a matter of hours versus years. This is a huge financial benefit as product testing failures, no matter how small make up a considerable cost to existing biopharma product development. We are not saying we are better than they are, we are just faster and have a huge economy of scale of virtual lab workers that cost us very little to feed and house. ****

[ 00 / 06 ]

[ FAQs ]

Answers to your common questions

Got questions? We have answers.

What kind of a company is Sawyer Boone?

Sawyer Boone Inc. is a Delaware C-Corp created to be a leading edge biotech research and development company and primary holder of valuable Intellectual Property (IP) supporting humane wildlife and animal welfare vaccines and therapeutics.

Sawyer Boone Inc. is applying for classification as a Service-Disabled Veteran-Owned Small Business (SDVOSB) and will update the site once this classification is approved.

Is Sawyer Boone publicly traded?  Can I invest?  

Sawyer Boone is a privately held company and is not publicly traded.  As a privately held company there may be opportunities to invest in our future and join our team.  Contact us for more information.  

What is an SDVOSB?

An SDVOSB stands for a Service-Disabled Veteran-Owned Small Business, a specialized federal contracting designation and socioeconomic program in the United States. 
The federal government has a statutory goal to award at least 5% of all federal contracting dollars to SDVOSBs each year. To help agencies meet this target, the program gives eligible businesses access to exclusive federal set-aside and sole-source contracts. 
Core Eligibility Requirements
To qualify for SDVOSB status, a business must meet the following criteria:
  • Small Business Status: The company must meet the small business size standards established by the U.S. Small Business Administration (SBA) for its specific industry and NAICS code.
  • Ownership: At least 51% of the business must be unconditionally owned and controlled by one or more service-disabled veterans. 
  • Management: One or more service-connected disabled veterans must manage the day-to-day operations and make long-term business decisions. 
  • Disability Rating: The veteran's disability must be service-connected (incurred or aggravated during active military service) and documented by the Department of Veterans Affairs (VA) or Department of Defense. Any disability rating from 1% to 100% qualifies. 

How realistic are your solutions?

Our solutions are currently undergoing detailed testing and analysis.  Once we receive additional funding, we will begin live animal and wet lab testing. The results will be the final determinant of the success of the designs and implementations, however, our extensive testing using digital analogs over hundred of thousands of iterations has resulted in remarkable efficacy that we expect will translate into the live testing.

What if you do not get the results you want?

If we do not get the results we want, then we go back into the design tools and rework.  The beauty of our designs and tools is that they are based on decades of real science and laboratory results and refined through Artifical Intelligence (AI) tools that help us run through infinitely more iterations of testing in a digital sandbox than we could possibly perform in a wet lab.  This results in results that would take a normal pharma or biotech laboratory months or even years to perform.  We can retool and retest in a matter of hours versus years.  This is a huge  financial benefit as product testing failures, no matter how small make up a considerable cost to existing biopharma product development.  We are not saying we are better than they are, we are just faster and have a huge economy of scale of virtual lab workers that cost us very little to feed and house.

Why isn't anyone else doing what you do?

They are!  It is just that we are doing it a little differently.  We are unique in that we are like a five year old child who has not learned about gravity yet.  Not being knowledgeable of the laws of gravity, a five year old does not believe they cannot fly. Often academic researchers are so bound by the knowledge and rules they have learned in University and structured lab settings and curriculum, that they do not know what is possible.  Invention is truly taking what is believed to be impossible, like flying, and finding a way to make it possible.

We do not believe in the law of Gravity. To us, it is just a ploy by birds to keep us from seeing the cool things they see every day. We do not believe in the law of Gravity. To us, it is just a ploy by birds to keep us from seeing the cool things they see every day. We do not believe in the law of Gravity. To us, it is just a ploy by birds to keep us from seeing the cool things they see every day. We do not believe in the law of Gravity. To us, it is just a ploy by birds to keep us from seeing the cool things they see every day. We do not believe in the law of Gravity. To us, it is just a ploy by birds to keep us from seeing the cool things they see every day. We do not believe in the law of Gravity. To us, it is just a ploy by birds to keep us from seeing the cool things they see every day.

[ 00 / 06 ]

[ CTA ]

Contact Us Today
BG

Ready to Help Us Reach Our Goals?

Contact us to learn more on how we streamline the process from ideas to solutions and accelerate new biotech product creation. Ask us how you can get involved.

THERE ARE NO MISTAKES, ONLY SOLUTIONS WAITING FOR A PROBLEM.

[ 00 / 09 ]

[ FOOTER ]

Sawyer Boone Inc.
PO Box 657
Steinhatchee, FL 32359

Email: info@sawyerboone.com

© 2026 SAWYER BOONE INC . ALL RIGHTS RESERVED.

BACK TO TOP